Class Action Filed Against Merck & Co., Inc. (MRK) - April 14, 2025 Deadline to Join - Contact Levi & Korsinsky
Portfolio Pulse from
A class action securities lawsuit has been filed against Merck & Co., Inc. alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 20, 2025 | 11:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck's stock price dropped over 9% following announcement of Gardasil shipment cessation in China and potential securities fraud allegations.
The class action lawsuit directly targets Merck's representations about Gardasil sales, which caused a significant stock price decline and potential legal and financial consequences.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100